Pharmacotherapy of overweight and obesity: weighting risks vs benefits
Overweight and obesity are one of the most important public health issues worldwide. According to WHO data, about 40% of adults 18 years and older present some degree of excess […]Leer Más ›
Canaglifozin: friend or foe?
Type 2 diabetes is the third most frequent disease affecting the population worldwide. Per data reported by the world health organization 422 million people have been diagnosed with this disease, […]Leer Más ›
Drug Therapies in the elderly patient: overvalued benefits or undervalued risks?
Many patients over 65 years of age, present a wide array of frequent symptomatology, which leads the treating physician to prescribe medication as a first line treatment to control these […]Leer Más ›
Naproxen, Ibuprofen and Diclofenac: Not as innocuous as it seems
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class and part of the available arsenal aimed at control and manage for both pain and inflammation. Most of us, although in different […]Leer Más ›
MC-21: Solutions that Improve the Efficiency of the Colombia Health System
Cartagena, May 19, 2016. The Convention Center at Hilton Cartagena de Indias Hotel was the stage where the new trends for the Latin America health sector were presented and debated. […]Leer Más ›
“Making Business in Puerto Rico”, a meeting of entrepreneurs that highlighted the advantages of the Island as a business partner
The delegation of the Commonwealth of Puerto Rico was headed by Juan Carlos Suárez, Under Secretary of the Department of Economic Development and Commerce Bogotá, Apri1 28, 2016 – In […]Leer Más ›